Effect of antihypertensive deprescribing on serious adverse events, mortality, and cardiovascular disease: Long-term follow-up of the OPTiMISE randomised controlled trial
SHEPPARD J., TEMPLE E., Wang A., SMITH A., Pollock S., Ford G., HOBBS R., KENEALY N., DE LUSIGNAN S., McCartney D., YU L-M., MCMANUS R.